跳至主要内容
临床试验/NCT07086183
NCT07086183尚未招募不适用

Assessing Surgical Perioperative rIsk in Patients on chRonic aspIrN Therapy Undergoing Elective Craniotomy for Aneurysm Clipping: a Prospective Multi-center Observational Study (ASPIRIN)

Mayo Clinic4 个研究点 分布在 3 个国家目标入组 100 人开始时间: 2026年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
Mayo Clinic
入组人数
100
试验地点
4
主要终点
Postoperative Hemorrhage Rate

研究概览

简要总结

This study is looking at how taking aspirin regularly affects bleeding during and after brain surgery. Specifically, it focuses on patients who are having elective surgery to clip a brain aneurysm.

Aspirin is commonly used to prevent heart attacks and strokes, but it can also increase the risk of bleeding. Doctors often face a tough decision: should patients stop taking aspirin before surgery to reduce bleeding risk, or continue it to prevent blood clots?

To help answer this question, researchers will observe 100 patients, some who take aspirin regularly and some who don't, at hospitals in the U.S., Russia, and Italy. They will not change any treatments but will collect information about bleeding during surgery, blood test results, and CT scans after surgery.

The goal is to better understand the risks of continuing aspirin and to help doctors make safer decisions for future patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age > or = 18 years old
  • •Patients willing to participate and provide an informed consent
  • •Patients undergoing elective craniotomy for cerebral aneurysm clipping
  • •Patients on chronic low-dose (75-100 mg) aspirin daily (aspirin group) or not on aspirin therapy for at least 7 days (control group) preoperatively.

排除标准

  • •Emergency craniotomy
  • •Use of other antiplatelet or anticoagulant medications within 7 days prior to surgery
  • •Known bleeding disorders (e.g. hemophilia, thrombocytopenia)
  • •History of intracranial hemorrhage unrelated to aneurysm
  • •Inability to provide informed consent

研究组 & 干预措施

Chronic aspirin

Patients on chronic aspirin

干预措施: Observation (Other)

No aspirin

Patients who are not on aspirin

干预措施: Observation (Other)

结局指标

主要结局

Postoperative Hemorrhage Rate

时间窗: 48 hours postoperatively

The incidence of postoperative hemorrhage detected on CT scans within 48 hours after surgery.

Intraoperative Blood Loss

时间窗: From start to end of surgery

Measured by the change in hemoglobin and hematocrit levels from preoperative baseline to immediate postoperative period.

次要结局

  • Subjective Bleeding Severity(From start to end of surgery)
  • Length of hospital stay(From end of surgery to day of discharge, up to 7 days)
  • Need for Blood Transfusion(From start of surgery to day of discharge, up to 7 days)
  • Surgical complications(From end of surgery to day of discharge, up to 7 days)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shaun Gruenbaum

Principal Investigator

Mayo Clinic

研究点 (4)

Loading locations...

相似试验